Is BDSI undervalued or overvalued?
As of 2025-03-27, the Intrinsic Value of BioDelivery Sciences International Inc (BDSI) is 6.52 USD. This BDSI valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 5.59 USD, the upside of BioDelivery Sciences International Inc is 16.60%. This means that BDSI is undervalued by 16.60%.
The range of the Intrinsic Value is 5.25 - 8.77 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 5.25 - 8.77 | 6.52 | 16.6% |
| DCF (Growth 10y) | 9.69 - 17.22 | 12.40 | 121.8% |
| DCF (EBITDA 5y) | 4.93 - 6.67 | 5.75 | 2.9% |
| DCF (EBITDA 10y) | 7.73 - 10.86 | 9.16 | 63.8% |
| Fair Value | 4.29 - 4.29 | 4.29 | -23.17% |
| P/E | 2.41 - 3.69 | 3.08 | -44.9% |
| EV/EBITDA | 3.11 - 4.45 | 3.77 | -32.6% |
| EPV | 3.35 - 4.56 | 3.96 | -29.2% |
| DDM - Stable | 7.11 - 15.33 | 11.22 | 100.7% |
| DDM - Multi | 4.47 - 7.81 | 5.71 | 2.2% |
| Market Cap (mil) | 552.29 |
| Beta | 0.55 |
| Outstanding shares (mil) | 98.80 |
| Enterprise Value (mil) | 496.77 |
| Market risk premium | 4.24% |
| Cost of Equity | 7.75% |
| Cost of Debt | 8.11% |
| WACC | 7.57% |